Pfizer Inc., 500 Arcola Road, Collegeville, PA, 19426, USA.
Pharmaceut Med. 2023 Mar;37(2):97-101. doi: 10.1007/s40290-023-00461-3. Epub 2023 Feb 14.
An ongoing and increasing shift is occurring in ways in which the healthcare community (healthcare providers, patients, biopharma) disseminates and consumes information. Adoption of digital technologies, accelerated by the virtual environment created by the COVID-19 pandemic, are leading to new and innovative ways in which medical and scientific information and data are communicated. Digital technologies have largely enabled these approaches and led to an explosive increase in availability of information. This article describes considerations in how the healthcare community, and Medical Affairs organizations in biopharma, can effectively harness these channels to communicate effectively, and incorporate changes in behaviors and approaches to redefine what medical information and data look like.
医疗保健界(医疗保健提供者、患者、生物制药)传播和获取信息的方式正在发生持续且不断增加的转变。数字技术的采用,由于 COVID-19 大流行所创造的虚拟环境而加速,正在导致医学和科学信息及数据交流的新的和创新的方式。数字技术在很大程度上实现了这些方法,并导致信息的可用性呈爆炸式增长。本文描述了医疗保健界,以及生物制药中的医学事务组织,如何有效地利用这些渠道进行有效沟通,并结合行为和方法的改变,重新定义医学信息和数据的样子。